Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000665285 | SCV000789378 | likely pathogenic | MPI-congenital disorder of glycosylation | 2017-01-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000665285 | SCV001590071 | pathogenic | MPI-congenital disorder of glycosylation | 2020-09-16 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in MPI are known to be pathogenic (PMID: 19862844). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with MPI-related conditions. ClinVar contains an entry for this variant (Variation ID: 550519). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Val294Glyfs*11) in the MPI gene. It is expected to result in an absent or disrupted protein product. |
Baylor Genetics | RCV000665285 | SCV004193716 | likely pathogenic | MPI-congenital disorder of glycosylation | 2023-02-01 | criteria provided, single submitter | clinical testing |